Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP933986.RAo3MUtTGo6QsPIoZ4uM3sywoOyXKeH5FlrjeLY3Y3_wE130_assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP933986.RAo3MUtTGo6QsPIoZ4uM3sywoOyXKeH5FlrjeLY3Y3_wE130_provenance.
• NP171972.RAgLbb5eHh1OV2_1IAwyX0k8ydijNdqCPOQjfRU_5Chz8130_assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171972.RAgLbb5eHh1OV2_1IAwyX0k8ydijNdqCPOQjfRU_5Chz8130_provenance.
• NP343137.RAct6cvCAvvNTTV5fYIK8Pso-20dUdDqHH6DgjBxnmdsY130_assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343137.RAct6cvCAvvNTTV5fYIK8Pso-20dUdDqHH6DgjBxnmdsY130_provenance.
• NP689367.RAqnNh9Zaf0NV3K6FReozeV2ZJpdlgVhHr9YycXDeV7To130_assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689367.RAqnNh9Zaf0NV3K6FReozeV2ZJpdlgVhHr9YycXDeV7To130_provenance.
• NP742255.RA9MMqTAAlKKAab1tuXVYZUSW2sQp6l9xp-n6RU_dsFVs130_assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP742255.RA9MMqTAAlKKAab1tuXVYZUSW2sQp6l9xp-n6RU_dsFVs130_provenance.
• NP613759.RAYnNGvanDtvHOAXOPBvDloztzdid4bcNhzrJS-WFf_tg130_assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613759.RAYnNGvanDtvHOAXOPBvDloztzdid4bcNhzrJS-WFf_tg130_provenance.
• NP603722.RALbJPkuYZqOKrdkR5WUVXX2urZVXdpjznjufNPtsuoKo130_assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP603722.RALbJPkuYZqOKrdkR5WUVXX2urZVXdpjznjufNPtsuoKo130_provenance.
• assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP525146.RABytTbpdjR9Tnucn0SAzLfNu2svyKYNytkx7O34gBTJg130_assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP525146.RABytTbpdjR9Tnucn0SAzLfNu2svyKYNytkx7O34gBTJg130_provenance.
• NP586048.RApdRjn_MydkCZMQr8kuJ2qwLqi2123AEDmWEiP_-56g4130_assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586048.RApdRjn_MydkCZMQr8kuJ2qwLqi2123AEDmWEiP_-56g4130_provenance.
• NP613464.RALgYcHbq5sXX3EkPKR9-Uxl4mmk6OaC0FgyP72qIE6BA130_assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613464.RALgYcHbq5sXX3EkPKR9-Uxl4mmk6OaC0FgyP72qIE6BA130_provenance.
• NP525824.RA_4P4Ikfbx6C-LYqJxc3tATVeFVe_WluO6Vr5pXxcmdM130_assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP525824.RA_4P4Ikfbx6C-LYqJxc3tATVeFVe_WluO6Vr5pXxcmdM130_provenance.
• NP586049.RAEjz8Zk13GeuEpjIFVjVVvdMfni9v37OZHocfmAbA2kg130_assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586049.RAEjz8Zk13GeuEpjIFVjVVvdMfni9v37OZHocfmAbA2kg130_provenance.
• NP586052.RAHZqawZitjNQ0TwKRvhx8JyIK8TVHiCHJgzkRlslvIuM130_assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586052.RAHZqawZitjNQ0TwKRvhx8JyIK8TVHiCHJgzkRlslvIuM130_provenance.
• NP586046.RA0cPMDTvDu63DVZ7dfMIKunsFyFfKmaATyyjiG2T7I38130_assertion description "[In samples collected at glioma diagnosis, KIT and PDGFRA amplifications were more frequent in anaplastic astrocytomas than in astrocytomas, oligodendrogliomas, and oligoastrocytomas [28% versus 5% (P = 0.012) and 33% versus 2% (P = 0.0008), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586046.RA0cPMDTvDu63DVZ7dfMIKunsFyFfKmaATyyjiG2T7I38130_provenance.